Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells

Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells

(2012) Angel Mauricio Castro-Gamero et al.   ANTI-CANCER DRUGS

Mechanisms of acquired resistance to targeted cancer therapies

(2012) Mark R Lackner et al.   Future Oncology

Phase I study of terameprocol in patients with recurrent high-grade glioma

(2012) S. A. Grossman et al.   NEURO-ONCOLOGY

Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation

(2012) Naduparambil Jacob et al.   OncoTargets and Therapy

Type I IFNs signaling and apoptosis resistance in glioblastoma cells

(2011) Andrea Sgorbissa et al.   APOPTOSIS

Targeting apoptosis pathways in glioblastoma

(2011) Günter Eisele et al.   CANCER LETTERS

Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress

(2011) Q. Wang et al.   CURRENT MEDICINAL CHEMISTRY

Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells

(2011) Kleiton Silva Borges et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma

(2011) Sebastian Reichert et al.   RADIOTHERAPY AND ONCOLOGY

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

(2010) Xiongpeng Zhu et al.   Journal of Hematology & Oncology

Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small Cell Lung Carcinoma

(2010) Yunguang Sun et al.   Journal of Thoracic Oncology

Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma

(2010) N. Gaspar et al.   MOLECULAR CANCER THERAPEUTICS

Advances in the Treatment of Malignant Gliomas

(2010) Mustafa Khasraw et al.   Current Oncology Reports

Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid

(2009) Ross O. Meyers et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR

(2009) Valeria Valente et al.   BMC MOLECULAR BIOLOGY

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development

(2009) Dorine A. Bax et al.   PLoS One

A haplotype variation affecting the mitochondrial transportation of hMYH protein could be a risk factor for colorectal cancer in Chinese

(2008) Huimei Chen et al.   BMC CANCER

Cancer cells survive with survivin

(2008) Hirofumi Yamamoto et al.   CANCER SCIENCE

Using gene expression profiling to identify a prognostic molecular spectrum in gliomas

(2008) Mitsuaki Shirahata et al.   CANCER SCIENCE

Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine

(2008) Elvis Terci Valera et al.   CHILDS NERVOUS SYSTEM

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines

(2008) T. Iwasa et al.   CLINICAL CANCER RESEARCH

Conventional and Gene Therapy Strategies for the Treatment of Brain Tumors

(2008) J. Benitez et al.   CURRENT MEDICINAL CHEMISTRY

Survivin Antisense Oligonucleotides Effectively Radiosensitize Colorectal Cancer Cells in Both Tissue Culture and Murine Xenograft Models

(2008) Franz Rödel et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Polyploidy in atypical grade II choroid plexus papilloma of the posterior fossa

(2008) María Sol Brassesco et al.   NEUROPATHOLOGY

New wirings in the survivin networks

(2008) D C Altieri   ONCOGENE